The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – October 2024 appeared first on Community Pharmacy England.
Community pharmacists, with experience in making referrals to pulmonary rehabilitation, are invited to participate in an online interview and focus groups to explore how best to discuss pulmonary rehabilitation with people living with chronic obstructive pulmonary disease (COPD). The study seeks to identify a way that encourages individuals to agree to be referred for this [...]
The post Share your views: Encouraging people with COPD to attend pulmonary rehabilitation appeared first on Community Pharmacy England.
All community pharmacies in England were asked to complete 10 screening questions as part of NHS England Community Pharmacy Assurance Framework (CPAF), and some contractors will be asked to complete the full CPAF questionnaire. Pharmacies may be selected for the full CPAF questionnaire if, for example, they did not complete the screening questions or if [...]
The post Full CPAF Questionnaire 2024/25 appeared first on Community Pharmacy England.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 2 September 2024) has been published and includes articles on: Valproate use in men: as a precaution, men and their partners should use effective contraception Letters and medicine recalls sent to healthcare professionals in August 2024. To see the latest [...]
The post MHRA Drug Safety Update: September 2024 appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Information: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) Drug alert number: EL (24)A/43 Date issued: 26 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) Company name: Sandoz Ltd Product name: Risperidone 1mg [...]
The post MHRA Class 4 Medicines Defect Information: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) appeared first on Community Pharmacy England.
Recent Comments